Track topics on Twitter Track topics that are important to you
The National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded Embolx a Small Business Innovation Research (SBIR) grant valued at $2m for further development of pressure-d...
Embolx, Inc., a medical device company, announced today that the Company has received a Federal Supply Schedule contract from the U.S. Department of Veterans Affairs (VA) t...
Embolx, Inc., a medical device company, announced today that the Company has been awarded a Small Business Innovation Research (SBIR) grant valued at $2 million from the Na...
The NIH awarded Sunnyvale, Calif.-based medical device firm Embolx a $2 million grant to support development of an advanced v -More-
Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically...
We have published hundreds of Embolx, Inc. news stories on BioPortfolio along with dozens of Embolx, Inc. Clinical Trials and PubMed Articles about Embolx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Embolx, Inc. Companies in our database. You can also find out about relevant Embolx, Inc. Drugs and Medications on this site too.
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...
Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...